Rajendra Anant Apandkar
About Rajendra Anant Apandkar
Data last updated:
Rajendra Anant Apandkar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Vrisha Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vrisha Pharmaceuticals Private Limited at ₹24.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vrisha Pharmaceuticals Private Limited U52310MH2005PTC156801 | Director | 13 Dec 2017 | 2005 | ₹24.9 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendra Anant Apandkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendra Anant Apandkar
Rajendra Anant Apandkar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Vrisha Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vrisha Pharmaceuticals Private Limited at ₹24.9 Lakh (FY 2025).
Rajendra Anant Apandkar is associated with 1 company as Director, including Vrisha Pharmaceuticals Private Limited (₹24.9 Lakh).
Rajendra Anant Apandkar has expertise in General Business.
Rajendra Anant Apandkar has 8 years in corporate governance.
By reported revenue, the largest current company of Rajendra Anant Apandkar is Vrisha Pharmaceuticals Private Limited, with revenue of ₹24.9 Lakh (FY 2025).
Rajendra Anant Apandkar currently holds positions at 1 company: Vrisha Pharmaceuticals Private Limited (₹24.9 Lakh).